Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors death
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Most Relevant Literature
- Molecular signatures in prion disease: altered death receptor pathways in a mouse model.
- Employing Piezoelectric Mg2+-Doped Hydroxyapatite to Target Death Receptor-Mediated Necroptosis: A S…
- Sweet modification and regulation of death receptor signalling pathway.
- Dabrafenib alleviates hepatotoxicity caused by lenvatinib via inhibiting the death receptor signalin…
- METTL16 deficiency attenuates apoptosis through translational control of extrinsic death receptor du…
Most Relevant Clinical Trials
- Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recur…
- An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Pro…
- Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participan…
- Apparent Life Threatening Events, Sudden Infant Death Syndrome and Muscarinic Receptors
- A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administe…
